KRYSTAL BIOTECH INC. - COMMON STOCK

187.86

21-February-25 16:45:00

15 minutes delayed

Stocks

+5.24

+2.87%

Today's range

184.12 - 189.19

ISIN

N/A

Source

NASDAQ

Krystal Biotech Provides Update on Pivotal GEM-3 Study of B-VEC for DEB

26 Apr 2021 16:05:00 By Nasdaq GlobeNewswire
Krystal Biotech Provides Updates from its Rare Genetic Lung Disease Pipeline

19 Apr 2021 08:00:01 By Nasdaq GlobeNewswire
Krystal Biotech Announces Completion of Patient Enrollment in the GEM-3 Pivotal Trial of B-VEC for the Treatment of Dystrophic Epidermolysis Bullosa

30 Mar 2021 08:00:02 By Nasdaq GlobeNewswire
Krystal Biotech to Participate in Upcoming Investor Conferences

29 Mar 2021 16:30:00 By Nasdaq GlobeNewswire
Krystal Biotech Announces Launch of Jeune, a Gene-Based Aesthetics Company, and Initial Phase 1 Safety Data for KB301 in Aesthetic Indications

24 Mar 2021 07:00:00 By Nasdaq GlobeNewswire
Krystal Biotech Provides Update on Operational Progress and Reports Fourth Quarter and Full Year 2020 Financial Results

01 Mar 2021 08:37:30 By Nasdaq GlobeNewswire
Krystal Biotech to Present at the Cowen 41st Annual Health Care Conference

23 Feb 2021 08:00:01 By Nasdaq GlobeNewswire
Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Stock

02 Feb 2021 20:50:57 By Nasdaq GlobeNewswire

<<
<
2
3
4
5
6
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.